| scholarly article | Q13442814 |
| P2093 | author name string | Xiaoying Liu | |
| Richard M Green | |||
| Kristy A Anderson | |||
| Matthew J Schipma | |||
| Anne S Henkel | |||
| Brian E LeCuyer | |||
| P2860 | cites work | Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet | Q43138230 |
| Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice | Q43224118 | ||
| Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease | Q44934521 | ||
| CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury | Q46823993 | ||
| Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis | Q82677113 | ||
| Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice | Q84526280 | ||
| Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks | Q24633890 | ||
| Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994 | Q28384968 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state | Q28572472 | ||
| Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease | Q29614897 | ||
| The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association | Q29617157 | ||
| The natural history of nonalcoholic fatty liver disease: a population-based cohort study | Q29617161 | ||
| Nonalcoholic fatty liver disease | Q29619354 | ||
| In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). | Q30452333 | ||
| Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver | Q34078580 | ||
| Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease | Q34404491 | ||
| Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease | Q34427653 | ||
| PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease | Q34759018 | ||
| Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition | Q35562084 | ||
| Cytokines and the pathogenesis of non-alcoholic steatohepatitis | Q35598104 | ||
| GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists | Q35724720 | ||
| A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease | Q36028519 | ||
| Endoplasmic reticulum stress in liver disease | Q36031838 | ||
| Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets | Q36061647 | ||
| GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics | Q36088447 | ||
| Reducing endoplasmic reticulum stress does not improve steatohepatitis in mice fed a methionine- and choline-deficient diet | Q36114917 | ||
| Silencing of lipid metabolism genes through IRE1α-mediated mRNA decay lowers plasma lipids in mice. | Q36330343 | ||
| IRE1α-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis | Q36600595 | ||
| Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease | Q36889026 | ||
| Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance | Q37038490 | ||
| GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information | Q37245619 | ||
| Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort | Q37259440 | ||
| The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease | Q37412003 | ||
| Endoplasmic reticulum stress, obesity and diabetes | Q37926034 | ||
| Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis | Q37953770 | ||
| Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent | Q40762653 | ||
| Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar? | Q41766493 | ||
| Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice | Q42428652 | ||
| P433 | issue | 12 | |
| P304 | page(s) | G965-74 | |
| P577 | publication date | 2015-10-15 | |
| P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
| P1476 | title | Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet | |
| P478 | volume | 309 |
| Q47216007 | 3D-Printed Gelatin Scaffolds of Differing Pore Geometry Modulate Hepatocyte Function and Gene Expression |
| Q55503094 | Apoptosis and non-alcoholic fatty liver diseases. |
| Q50420689 | Developmental origins of non-alcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. |
| Q64057135 | Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis |
| Q97522970 | Endoplasmic reticulum stress and liver diseases |
| Q47643998 | Farnesoid X Receptor Signaling Activates the Hepatic X-box Binding Protein 1 Pathway in vitro and in Mice |
| Q39048675 | Hepatic deletion of X-box binding protein 1 impairs bile acid metabolism in mice |
| Q102220441 | Hepatocyte-specific deletion of XBP1 sensitizes mice to liver injury through hyperactivation of IRE1α |
| Q64999429 | IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs. |
| Q47104419 | Induction of fibroblast growth factor 21 does not require activation of the hepatic X-box binding protein 1 in mice |
| Q87753980 | Interaction between stress responses and circadian metabolism in metabolic disease |
| Q38759104 | Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors |
| Q49843619 | Liver function and dysfunction - a unique window into the physiological reach of ER stress and the unfolded protein response |
| Q57057500 | Loss of hepatocyte β-Catenin protects mice from experimental porphyria-associated liver injury |
| Q37519318 | The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy |
| Q36302806 | Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. |
Search more.